Document is current
Any future updates will be listed below
-
Authors
Park, Ji Yong
An, Jung Nam
Lee, Seong Min
Ann, Young Chan
Bae, Eunjin
Yoo, Kyung Don
Kim, Yong Chul
Chae, Hyeri
Oh, Joo Yeon
Yoo, Ran Ji
Kim, Dong Ki
Hong, Sung Hyun
Kim, Yon Su
Lee, Yun-Sang
Yang, Seung Hee
-
Funding
Funding for this research was provided by:
Ministry of SMEs and Startups (RS-2024-00419832)
Ministry of SMEs and Startups (RS-2023-00304101)
National Research Foundation of Korea (RS-2024-00464001)
National Research Foundation of Korea (2021R1A2C300942714)
National Research Foundation of Korea (RS-2023-NR077156)
Korea Health Industry Development Institute (HI23C107200)
- License Information
-
More Information
Article History
Received: 5 October 2025
Accepted: 12 January 2026
First Online: 29 January 2026
Declarations
:
: The animal experiments were approved by the Institutional Animal Care and Use Committee of Seoul National University Hospital (SNUH) (23-0043-S1A0). The use of human primary cells was approved by the Seoul National University College of Medicine/Seoul National University Hospital Institutional Review Board (SNUCM/SNUH IRB; IRB No. H-2203-053-1303), and the study adhered to the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
